健民集团: 健民集团关于董事会换届选举的公告

Core Viewpoint - The announcement details the upcoming election of the 11th Board of Directors for Jianmin Pharmaceutical Group Co., Ltd., following the expiration of the 10th Board's term, highlighting the nomination of candidates and the process for their election [1][3]. Group 1: Board Election Process - The 11th Board of Directors will consist of nine members, with eight candidates nominated for election by the shareholders' meeting, including both non-independent and independent directors [3][4]. - The candidates for the 11th Board include Pei Rong, Wang Siyang, Yuan Pingdong, Wang Jun, and Xu Liang as non-independent directors, and Guo Yunpei, Yang Zhi, and Xin Jinguo as independent directors [1][2]. Group 2: Candidate Qualifications - The candidates have been deemed qualified to serve as directors, with no disqualifying conditions as per relevant laws and regulations, and no recent administrative penalties from the China Securities Regulatory Commission [2]. - The independent director candidates possess the necessary educational backgrounds and work experiences to fulfill their responsibilities, having obtained the required qualifications recognized by the China Securities Regulatory Commission [2]. Group 3: Future Arrangements - Following the approval of the revised Articles of Association, a new employee director will be elected through a democratic process, alongside the directors elected by the shareholders [3]. - The term for the newly elected Board members will be three years, starting from the date of the shareholders' meeting approval [3]. Group 4: Acknowledgments - The company expresses gratitude to outgoing Chairman He Qin and independent director Li Shuqiu for their contributions to the company's development during their tenure [4].